U.S. Markets open in 7 hrs 14 mins
S&P Futures
3,300.25+36.75(+1.13%)Dow Futures
26,695.00+286.00(+1.08%)Nasdaq Futures
11,256.25+123.50(+1.11%)
Athersys, Inc. (ATHX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.6300+0.0100 (+0.62%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 1.6200 |
| Open | 1.5900 |
| Bid | 0.0000 x 3200 |
| Ask | 0.0000 x 3100 |
| Day's Range | 1.5600 - 1.6700 |
| 52 Week Range | 1.1300 - 4.3800 |
| Volume | 1,364,507 |
| Avg. Volume | 1,848,320 |
| Market Cap | 321.769M |
| Beta (5Y Monthly) | -1.75 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3370 |
| Earnings Date | Nov 09, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.40 |
- Business Wire
Athersys to Host Third Quarter Financial Results Call
Athersys, Inc. (Nasdaq: ATHX) will release its third quarter 2020 financial results on Monday, November 9, 2020.
- Zacks
Do Options Traders Know Something About Athersys (ATHX) Stock We Don't?
Investors need to pay close attention to Athersys (ATHX) stock based on the movements in the options market lately.
- Zacks
Athersys Gets FDA's RMAT Designation for Cell Therapy in ARDS
The FDA bestows a Regenerative Medicine Advanced Therapy status on Athersys' (ATHX) MultiStem cell therapy candidate for treating acute respiratory distress syndrome.
© 2020 Verizon Media. All rights reserved.
